Search Results 851-860 of 21218 for Informed consent

1. Study of Treg Therapy in Subclinical Inflammation in Kidney Transplantation (TASK) - Mayo Clinic

   Subject must be able to understand and provide informed consent. · Age ≥ 18 years of age at the time of study entry. · Recipients of non- Human Leukocyte Antigen ...

2. A Study Of Avatrombopag For The Treatment Of Thrombocytopenia In Patients With Chronic Liver Disease Undergoing An Elective Procedure - Mayo Clinic

   Provide written informed consent; Willing and able to comply with all aspects of the protocol. Exclusion Criteria. Any history of arterial or venous thrombosis ...

3. Digital Care's Burden on Patients - Clinical Trials

   ... informed consent. Eligibility last updated 7/26/23. Questions regarding updates should be directed to the study team contact. Participating Mayo Clinic ...

4. A Study to Evaluate Support Services for Managing Urological Conditions - Mayo Clinic

   Participants with certain physical and mental disabilities that might interfere with their ability to give informed consent, cooperate with the researcher, or ...

5. A Study of Lutetium Lu 177 Dotatate (Lutathera®) in Patients with Inoperable, Progressive Meningioma after External Beam Radiation Therapy - Mayo Clinic

   * Provide written informed consent * Willing to return to enrolling institution for follow-up (during the Active Monitoring Phase and the Event Monitoring ...

6. SPORT-DMG - Mayo Clinic

   Patient or caregiver willing and able to provide written informed consent. Primary language of English or Spanish for patients and their caregiver. Negative ...

7. Efficacy and Safety of Etripamil for the Termination of Spontaneous PSVT. NODE-301 - Mayo Clinic

   ... informed consent until 30 days after the last administration of study drug. Females of childbearing potential should have a negative serum pregnancy test ...

8. SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing’s Syndrome - Mayo Clinic

   Any major surgery, or significant post-operative sequelae, within 1 month prior to informed consent or planned during the trial. Pregnant, lactating, or ...

9. Regenerative Biotherapeutic Development With Neonatally-derived Tissues - Mayo Clinic

   Able and willing to provide written informed consent. Exclusion Criteria: Failure to meet 21 CFR 1271 donor eligibility criteria based on responses to a ...

10. Pembrolizumab, Chemotherapy, and Radiation Therapy With or Without Surgery in Treating Patients With Anaplastic Thyroid Cancer - Mayo Clinic

    Provide written informed consent; Willing to return to enrolling institution for follow-up (during the active monitoring phase of the study); Willing to ...